Phase i option exercise
Ended Purchase Order Awarded Last action
- Contract number
- W911QY16P0048
- Awardee
-
Cytosorbents Medical Inc. UEI LSF2KFUSY4K7
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $149,936
Award facts
- Contract value 100% obligated
- $149,935.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Monmouth Junction, South Brunswick Township, NJ 08852, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $49,939 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $99,997 |
About this award
This is a firm fixed-price purchase order awarded by the Joint Program Executive Office for Chemical and Biological Defense, a U.S. Department of Defense agency, to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The $149,935.98 contract is for research and prototype development services under the Small Business Innovation Research (SBIR) Phase I program. The contract is set aside for small businesses. Cytosorbents Medical Inc., the prime contractor, is responsible for conducting research to advance its blood purification technologies, including an extracorporeal cytokine adsorber to treat septic shock, a potassium adsorber to treat hyperkalemia, and an adsorber to remove anti-A and anti-B antibodies from blood for transfusion. The company has also received federal grants from the National Institutes of Health and Department of the Army Medical Command to further develop these medical device technologies.
Quick answers
Who was awarded contract W911QY16P0048?
W911QY16P0048 was awarded to Cytosorbents Medical Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on December 23, 2015.
How much is contract W911QY16P0048 worth?
The government has obligated $149,936 on W911QY16P0048.
Which agency awarded contract W911QY16P0048?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY16P0048, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY16P0048 competed?
The extent of competition for W911QY16P0048 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award